Literature DB >> 24939597

Prognostic factors for postoperative morbidity and tumour response after neoadjuvant chemoradiation followed by resection for rectal cancer.

Annefleur E M Berkel1, Dankert P Woutersen, Job van der Palen, Joost M Klaase.   

Abstract

BACKGROUND AND
PURPOSE: In patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation followed by rectal resection, postoperative morbidity is a significant clinical problem. Pathologic complete tumour response seems to give the best prognosis in the long term. Little is known about the factors that are associated with postoperative complications and pathologic complete response. The aim of this retrospective study was to identify and describe these factors.
METHODS: Ninety-nine consecutive patients with locally advanced rectal cancer who underwent neoadjuvant chemoradiation (50 Gy and capecitabine) followed by surgery at our institute between January 2007 and May 2012 were identified. Postoperative complications were graded according to the Clavien-Dindo classification. Pathologic tumour response was categorized as complete response or no/partial response.
RESULTS: Postoperative complications occurred in 68 patients (69%) and grade 3-5 complications in 25 patients (25%). The 30-day and 90-day mortality were 1% (n = 1) and 2% (n = 2), respectively. A young age (p = 0.021) and a preoperative or postoperative blood transfusion (p = 0.015) independently predicted complications. Intraoperative or postoperative blood transfusion (p = 0.007) and ypT0-1 stage (p = 0.037) were independent predictors for grade 3-5 complications. Complete response rate was 22% (n = 22); 4% (n = 4) of patients showed no response. No independent factors predicting complete response were found.
CONCLUSIONS: Neoadjuvant chemoradiation followed by rectal resection is associated with significant postoperative morbidity but minimal postoperative mortality. A complete response rate of 22% was achieved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24939597     DOI: 10.1007/s11605-014-2559-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  29 in total

1.  Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure.

Authors:  Kelli M Bullard; Judith L Trudel; Nancy N Baxter; David A Rothenberger
Journal:  Dis Colon Rectum       Date:  2005-03       Impact factor: 4.585

2.  Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma.

Authors:  David E Stein; Najjia N Mahmoud; Pramila Rani Anné; Deborah G Rose; Gerald A Isenberg; Scott D Goldstein; Edith Mitchell; Robert D Fry
Journal:  Dis Colon Rectum       Date:  2003-04       Impact factor: 4.585

3.  Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience.

Authors:  N A Janjan; V S Khoo; J Abbruzzese; R Pazdur; R Dubrow; K R Cleary; P K Allen; P M Lynch; G Glober; R Wolff; T A Rich; J Skibber
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-15       Impact factor: 7.038

4.  Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

Authors:  Claus Rödel; Peter Martus; Thomas Papadoupolos; Laszlo Füzesi; Martin Klimpfinger; Rainer Fietkau; Torsten Liersch; Werner Hohenberger; Rudolf Raab; Rolf Sauer; Christian Wittekind
Journal:  J Clin Oncol       Date:  2005-10-24       Impact factor: 44.544

5.  Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery.

Authors:  Luiz Felipe de Campos-Lobato; Daniel P Geisler; Andre da Luz Moreira; Luca Stocchi; David Dietz; Matthew F Kalady
Journal:  J Gastrointest Surg       Date:  2010-12-08       Impact factor: 3.452

6.  Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer.

Authors:  Cam-Ly Tran; Sejal Udani; Alicia Holt; Tracey Arnell; Ravin Kumar; Michael J Stamos
Journal:  Am J Surg       Date:  2006-12       Impact factor: 2.565

Review 7.  Myocutaneous flap reconstruction of the pelvis after abdominoperineal excision.

Authors:  P J Nisar; H J Scott
Journal:  Colorectal Dis       Date:  2008-11-14       Impact factor: 3.788

8.  Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer.

Authors:  Matthew F Kalady; Luiz Felipe de Campos-Lobato; Luca Stocchi; Daniel P Geisler; David Dietz; Ian C Lavery; Victor W Fazio
Journal:  Ann Surg       Date:  2009-10       Impact factor: 12.969

9.  Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome?

Authors:  Angelita Habr-Gama; Rodrigo Oliva Perez; Igor Proscurshim; Rafael Miyashiro Nunes Dos Santos; Desiderio Kiss; Joaquim Gama-Rodrigues; Ivan Cecconello
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-30       Impact factor: 7.038

10.  Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.

Authors:  C M Dolinsky; N N Mahmoud; R Mick; W Sun; R W Whittington; L J Solin; D G Haller; B J Giantonio; P J O'Dwyer; E F Rosato; R D Fry; J M Metz
Journal:  J Surg Oncol       Date:  2007-09-01       Impact factor: 3.454

View more
  4 in total

1.  Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.

Authors:  Eisar Al-Sukhni; Kristopher Attwood; David M Mattson; Emmanuel Gabriel; Steven J Nurkin
Journal:  Ann Surg Oncol       Date:  2015-12-14       Impact factor: 5.344

Review 2.  Effect of pathological complete response after neoadjuvant chemoradiotherapy on postoperative complications of rectal cancer: a systematic review and meta-analysis.

Authors:  J Yang; W Wang; Y Luo; S Huang; Z Fu
Journal:  Tech Coloproctol       Date:  2022-01-20       Impact factor: 3.781

3.  How Long is It Safe to Wait for Breast Surgery After Completion of Neoadjuvant Chemotherapy?

Authors:  Tianyi Ma; Yan Mao; Haibo Wang
Journal:  Cancer Manag Res       Date:  2021-02-03       Impact factor: 3.989

4.  The taTME learning curve for mid-low rectal cancer: a single-center experience in China.

Authors:  Fengming Xu; Yiqiao Zhang; Jiafu Yan; Bowen Xu; Guocong Wu; Zhengyang Yang; Liting Sun; Xiao Zhang; Hongwei Yao; Zhongtao Zhang
Journal:  World J Surg Oncol       Date:  2022-09-23       Impact factor: 3.253

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.